Ergothioneine

Also sold as: L-Ergothioneine

Best-in-class: Ergothioneine

A unique mushroom-derived antioxidant that cells actively transport and retain (via a dedicated transporter, OCTN1) — earning it the nickname 'the longevity vitamin.'

How Ergothioneine actually works

The strongest argument for ergothioneine isn't its antioxidant chemistry — it's that humans have a dedicated transporter for it. OCTN1 exists apparently to pull this one compound into cells and concentrate it, particularly in tissues under oxidative stress: liver, kidney, red blood cells, eyes. Evolution doesn't usually build a specific transporter for a molecule with no function, which is why some researchers argue it should be classified as a vitamin. Humans can't synthesize it; it comes almost entirely from mushrooms and from bacteria in the food chain.

Where to get Ergothioneine

The evidence for Ergothioneine

Graded by what exists behind each claim.

✅ Clinically validated

• Human studies link higher ergothioneine levels to lower cardiovascular disease and mortality; it accumulates in tissues under oxidative stress.
• Acts as a cytoprotective antioxidant in mitochondria and other stressed tissues.

📊 Correlative data

• Blood ergothioneine declines with age and low levels are associated with frailty and cognitive decline.

🧪 Theoretical / extrapolated benefits

• Its dedicated transporter suggests a real physiological role — a genuine candidate 'longevity nutrient,' though intervention trials are early.

How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →

What Ergothioneine actually does

Ergothioneine is the set-point argument run backwards: the body defends it upward, keeps it for weeks, and has no route to destroy it. It is a betaine of 2-thio-L-histidine, made only by certain fungi, mycobacteria and cyanobacteria, which means every molecule in you was eaten. Humans cannot synthesize it and yet a dedicated transporter exists for it, which is the strongest circumstantial argument in nutrition that a compound has a job.

The transporter is the controller and it is remarkably selective. OCTN1, the product of SLC22A4, transports ergothioneine with high affinity and concentrates it inside cells against a steep gradient, reaching tissue concentrations far above plasma Pochini 2022. Expression is highest in bone marrow, erythrocytes, liver, kidney, lens and seminal fluid -- the tissues under the greatest oxidative load. So the distribution is not set by where the blood goes; it is set by where the transporter is.

The chemistry it does is unusual and it is why nothing destroys it. Ergothioneine exists overwhelmingly as the thione tautomer at physiological pH rather than the thiol, so unlike glutathione or cysteine it does not autoxidize, does not form disulfides readily and does not participate in the ordinary thiol redox cycling. It scavenges hydroxyl radical, hypochlorous acid, singlet oxygen and peroxynitrite, and it chelates divalent metals, without becoming a pro-oxidant in the process Cheah 2021.

Which produces the pharmacokinetic fact that reframes the dose. With avid uptake, no known catabolic pathway and renal reabsorption by the same transporter family, the body's ergothioneine has a residence time measured in weeks rather than hours Cheah 2021 Thomas 2024. A daily 5 mg capsule is not producing a daily peak; it is slowly raising a pool toward a ceiling set by how much transporter you express.

And that ceiling is the honest limit of the product. If tissue level is transporter-determined, then above the intake that saturates uptake, more milligrams buy nothing Pochini 2022. Nobody knows where that intake is.

Cell, rodent, human — and where it stops

The human evidence is observational, it is strong for observational evidence, and it has never been converted into an intervention.

What has been observed. Low plasma ergothioneine predicted cognitive and functional decline in an elderly cohort attending memory clinics Wu 2022, and the broader nutritional literature now argues it should be treated as a dietary micronutrient required for healthy aging Tian 2023. Reviews have gone further and framed it as a candidate geroprotector against specific hallmarks of aging Zhao 2026.

The specific obstacle is that a transported, retained molecule makes a perfect confounded biomarker. Plasma ergothioneine reflects mushroom intake, transporter expression and general dietary quality, and all three track health. An association between a low level and decline Wu 2022 is therefore equally consistent with ergothioneine being protective and with it being a marker of who was already well.

The mechanistic step that would break the tie has not been taken. No randomized trial has raised plasma ergothioneine in people and measured a hard outcome. The reviews say this explicitly Tian 2023 Zhao 2026, and it is the single most important sentence in the literature.

And the red cell work suggests where an intervention should look first. Erythrocytes carry a large share of circulating ergothioneine and its role there has been reviewed specifically Thomas 2024, which makes red cell parameters -- and stored blood quality -- a more tractable near-term endpoint than cognition.

Ergothioneine — which form, and does it matter

There is only one molecule and it is chiral, so the form question is stereochemistry and provenance. The natural compound is L-ergothioneine, and the transporter is stereoselective for it. Fermentation-derived material is L; a synthetic route can produce the D form or a mixture, which the transporter handles differently Pochini 2022. A panel that says only ergothioneine has not answered the only chemical question this ingredient has.

Mushrooms are the dietary form and they are not equivalent by weight. Content varies by species over roughly an order of magnitude, with oyster and king oyster mushrooms among the richest and common white button mushrooms much lower Tian 2023. Ergothioneine is heat-stable, so cooking does not destroy it, which is unusual for a food antioxidant and is a genuine practical point.

The dose range on the shelf is 5 to 25 mg and it is not arbitrary. Typical Western dietary intake is roughly 1 to 5 mg per day, so a 5 mg capsule roughly doubles a normal intake and a 25 mg capsule is an order of magnitude above it Cheah 2021. Because the pool fills slowly and empties slowly, the difference between those two doses is mostly a difference in how fast you reach the same plateau.

Which makes timing and food irrelevant here, unusually. A molecule with a residence time of weeks does not care whether today's capsule was taken with breakfast Thomas 2024. Consistency over months is the only administration variable that matters.

What would have to be true, and how you would know it was not

1. The accumulation prediction, and it is the defining one. Plasma or whole-blood ergothioneine at baseline, 4 weeks and 12 weeks on 5 mg daily. Predict a slow rise that is still climbing at 4 weeks and approaching a plateau by 12, because uptake is avid and clearance is minimal Cheah 2021. If the level peaks and falls between doses, everything on this page about retention is wrong.

2. The washout prediction, which is the same fact from the other side. Stop after 12 weeks and re-measure at 4 and 8 weeks. Predict the level is still well above baseline at 4 weeks. No other antioxidant supplement on this shelf would behave that way Thomas 2024.

3. The oxidative damage prediction, at 12 weeks. High-sensitivity C-reactive protein and, if available, a validated oxidative damage marker such as urinary 8-hydroxy-2'-deoxyguanosine. Predict little or no change in a healthy person, because the reviews describe a candidate mechanism rather than a demonstrated human effect Zhao 2026.

4. The red cell prediction, which is the most tractable endpoint. Reticulocyte count and red cell distribution width at baseline and 12 weeks. Predict no change in health, and predict this is the compartment where a real effect would appear first, given how much of the body's ergothioneine sits there Thomas 2024.

5. The trial that would settle it. Randomize older adults with low plasma ergothioneine to supplementation or placebo for two years with a cognitive battery such as the Montreal Cognitive Assessment as the endpoint. Prediction, stated as a genuine coin-flip: the biomarker association Wu 2022 could reflect causation or reflect who was already healthy, and only this design can tell them apart Tian 2023.

What nobody has tested yet

Nobody has run a randomized outcome trial. Every human claim for ergothioneine rests on association Wu 2022 plus mechanism Cheah 2021, and the reviews that advocate for it say so plainly Tian 2023.

Nobody knows the saturating intake. Tissue level is set by transporter capacity Pochini 2022, so there is an intake above which more is wasted, and no dose-ranging study has located it. The 5 to 25 mg range on the shelf is a market convention, not a finding.

Nobody has established what a physiological deficiency looks like. There is no defined deficiency syndrome and no reference range in clinical use Tian 2023, which means a reader cannot currently find out whether they are low.

And nobody knows what OCTN1 variation does to the response. The transporter is polymorphic and its variants are associated with inflammatory disease Pochini 2022. Whether a low-transport genotype makes supplementation more necessary or simply less effective is unanswered, and it is the question that would decide who should take it Zhao 2026.

Ergothioneine — its own safety story, not its category's

The honest safety statement here is unusually clean, and the reason it is clean is also the reason to be careful. No consistent adverse effects have been reported at supplemental doses and no drug interactions are established Cheah 2021. The trial base is short and small, so the absence of reports is weaker evidence than it looks Tian 2023.

The property that deserves the most thought is retention. A compound the body concentrates and does not degrade Pochini 2022 accumulates over months, which means any effect -- wanted or unwanted -- appears late and resolves slowly. That is the opposite risk profile from most of this shelf and it argues for modest doses over long periods rather than the reverse.

The transporter is shared, which is where a future interaction would come from. OCTN1 also handles cationic drugs, and it is studied partly for that reason Pochini 2022. No clinically important interaction has been demonstrated, and the mechanism for one exists, so it is worth mentioning to a prescriber on a narrow-window cationic drug rather than assuming inertness.

Mushroom allergy is the mundane contraindication. Most supplemental ergothioneine is fermentation-derived rather than mushroom-extracted, but a reader avoiding fungi for allergy should check the source on the label rather than the molecule Tian 2023.

And the fair summary is that this is a well-tolerated compound with an unproven clinical case. The geroprotector framing is a hypothesis under active review Zhao 2026, not a finding, and buying it is buying a plausible bet rather than a demonstrated effect. Nothing here is medical advice, and none of these statements has been evaluated by the Food and Drug Administration.

Sources read for this page

• Pochini L. OCTN1: A Widely Studied but Still Enigmatic Organic Cation Transporter Linked to Human Pathology and Drug Interactions. Int J Mol Sci 2022 · PMID 35055100
• Cheah IK. Ergothioneine, recent developments. Redox Biol 2021 · PMID 33558182
• Tian X. Ergothioneine: an underrecognised dietary micronutrient required for healthy ageing?. Br J Nutr 2023 · PMID 38018890
• Thomas TA. The Role of Ergothioneine in Red Blood Cell Biology: A Review and Perspective. Antioxidants (Basel) 2024 · PMID 38929156
• Zhao P. Ergothioneine as a Potential Geroprotector: Targeting Molecular Hallmarks of Ageing and Age-Related Diseases. Ageing Res Rev 2026 · PMID 42107722
• Wu LY. Low Plasma Ergothioneine Predicts Cognitive and Functional Decline in an Elderly Cohort Attending Memory Clinics. Antioxidants (Basel) 2022 · PMID 36139790

How you would know if it worked

Ergothioneine — safety & side effects

Bloodwork to run alongside Ergothioneine

Baseline first, then again at 8–12 weeks.

The Longevity Baseline panel covers these in one order — 13 markers, $219.10 with the discount applied.

Check results you already have → · All 103 markers A–Z

Ergothioneine — frequently asked questions

What Ergothioneine is used for

Ergothioneine appears under 2 goals in the goal router.

Related Longevity & Antioxidants supplements

← Browse the full Supplement Vault

↑ Back to on this page